Oncology Institute (TOI) Return on Invested Capital (2021 - 2026)

Oncology Institute (TOI) has reported Return on Invested Capital for 6 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.

• Return on Invested Capital for Q1 2026 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (changed N/A YoY), and the FY2025 annual result was 0.0%, changed N/A from the prior year.
• Return on Invested Capital was 0.01% for Q1 2026 at Oncology Institute, up from 0.01% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.01% in Q4 2022 and troughed at 0.01% in Q2 2025.
• Average Return on Invested Capital over 5 years is 0.0%, with a median of 0.01% recorded in 2026.
• Year-over-year, Return on Invested Capital climbed 1 bps in 2022 and declined 1 bps in 2023.
• Over 5 years, Return on Invested Capital stood at 0.01% in 2022, then tumbled by 177 bps to 0.01% in 2023, then slipped by 9 bps to 0.01% in 2024, then fell by 3 bps to 0.01% in 2025, then climbed by 8 bps to 0.01% in 2026.
• Per Business Quant data, the three most recent Return on Invested Capital figures were 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.